A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors ...
In patients with type 2 diabetes (T2D), the risks for gastroesophageal reflux disease (GERD) and GERD-related complications were greater with GLP-1 receptor agonist (RA) use than with SGLT2 inhibitor ...
The diagnosis and optimal treatment of the extraesophageal complications of gastroesophageal reflux disease (GERD) have been long-standing topics in evolution. A decade ago, it was believed that ...
Severe acid reflux can be an emergency. People should seek medical attention if they experience bloody vomit or stools, difficulty swallowing, or unexplained weight loss. These symptoms may result ...
July 14 (UPI) --Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says. People with type 2 diabetes were more likely to suffer from ...
Acid reflux, heartburn, and gastroesophageal reflux disease (GERD) are often confused, yet each condition affects digestive health differently. Acid reflux occurs when stomach acid flows back into the ...
Heartburn that keeps returning is not something to ignore. Frequent acid reflux may point to Gastroesophageal Reflux Disease ...
A persistent bad taste in the mouth may signal acid reflux, digestive issues, liver disease, infections, or nutritional ...
The diagnosis of GERD varies based on patient symptoms and may include upper endoscopy or reflux testing. Communication with PCPs helps improve patient care and provides opportunity for education. The ...
No evidence supports a significant link between gastroesophageal reflux disease (GERD) and pancreatitis. However, they share some risk factors, such as excessive alcohol consumption and obesity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results